McIlrath & Eck’s Sabra Healthcare REIT SBRA Stock Holding History

McIlrath & Eck’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,500	Closed	-$85.2K	–	1687
2025 Q4	$85.2K	Buy	+4,500	New	+$83.4K	0.01%	270

Other funds holding SBRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

McIlrath & Eck's SBRA Position: Q1 2026 in Review

McIlrath & Eck sold out of Sabra Healthcare REIT (SBRA) in Q1 2026, closing a stake of 4,500 shares — an estimated $85.2K sold.

McIlrath & Eck first reported a position in SBRA in Q4 2025 and held it in 1 quarter. The position peaked at $85.2K in Q4 2025. 463 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

McIlrath & Eck reported no remaining Sabra Healthcare REIT position as of Q1 2026 after selling out during the quarter.
McIlrath & Eck sold 4,500 Sabra Healthcare REIT shares in Q1 2026, an estimated $85.2K.
McIlrath & Eck first reported a position in Sabra Healthcare REIT in Q4 2025 and held it in 1 quarter.
McIlrath & Eck's Sabra Healthcare REIT position peaked at $85.2K in Q4 2025.
463 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.